{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:34:26Z","timestamp":1792010066256,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1124\/dmd.116.073957","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T01:40:30Z","timestamp":1483494030000},"page":"939-946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the Model for Passive Placental Permeability Drugs"],"prefix":"10.1016","volume":"45","author":[{"given":"Zufei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jashvant D.","family":"Unadkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.116.073957_bib1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11597440-000000000-00000","article-title":"Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling","volume":"51","author":"Abduljalil","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.116.073957_bib2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0731-7085(91)80246-6","article-title":"Solubility and acid-base behaviour of midazolam in media of different pH, studied by ultraviolet spectrophotometry with multicomponent software","volume":"9","author":"Andersin","year":"1991","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.116.073957_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.116.073957_bib4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1592\/phco.20.11.917.35263","article-title":"Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infection","volume":"20","author":"Anderson","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1124\/dmd.116.073957_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.clpt.6100126","article-title":"Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies","volume":"81","author":"Andrew","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.116.073957_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2125.1981.tb00533.x","article-title":"Comparative pharmacokinetics of theophylline and aminophylline in man","volume":"11","author":"Aslaksen","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/138920007779315053","article-title":"Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver","volume":"8","author":"Barter","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.116.073957_bib8","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1124\/dmd.108.021311","article-title":"Covariation of human microsomal protein per gram of liver with age: absence of influence of operator and sample storage may justify interlaboratory data pooling","volume":"36","author":"Barter","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073957_bib9","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/0002-9378(92)91742-S","article-title":"The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta","volume":"167","author":"Bawdon","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/dmd.116.073957_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1742-7843.2009.00498.x","article-title":"Predicting drug disposition via application of a Biopharmaceutics Drug Disposition Classification System","volume":"106","author":"Benet","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"Suppl 1","key":"10.1124\/dmd.116.073957_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0163-4453(89)80076-3","article-title":"A review of the pharmacokinetics of zidovudine in man","volume":"18","author":"Cload","year":"1989","journal-title":"J Infect"},{"key":"10.1124\/dmd.116.073957_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/dmd.107.016865","volume":"36","author":"Collett","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073957_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0006-2952(01)00890-5","article-title":"UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at term","volume":"63","author":"Collier","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198917010-00001","article-title":"Clinical pharmacokinetics of zidovudine: an overview of current data","volume":"17","author":"Collins","year":"1989","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.116.073957_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0026-895X(25)10994-2","article-title":"Catabolism of 3\u2032-azido-3\u2032-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3\u2032-amino-3\u2032-deoxythymidine, a highly toxic catabolite for human bone marrow cells","volume":"39","author":"Cretton","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0143-4004(05)80207-3","article-title":"Nucleoside transport by perfused human placenta","volume":"14","author":"Dancis","year":"1993","journal-title":"Placenta"},{"key":"10.1124\/dmd.116.073957_bib17","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1002\/jps.21744","article-title":"Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK-MDR1, and Caco-2 cell monolayers","volume":"98","author":"de Souza","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.116.073957_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bcp.12815","article-title":"Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models","volume":"81","author":"De Sousa Mendes","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib19","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1002\/jps.22674","article-title":"Development of a new permeability assay using low-efflux MDCKII cells","volume":"100","author":"Di","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.116.073957_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/dmd.104.001230","article-title":"The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A\/1B knockout mouse model","volume":"33","author":"Doran","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073957_bib21","first-page":"325","article-title":"Fetal drug therapy","volume":"159","author":"Evans","year":"1993","journal-title":"West J Med"},{"key":"10.1124\/dmd.116.073957_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/00498254.2013.828362","article-title":"Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeys","volume":"44","author":"Furukawa","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.116.073957_bib23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/AAC.44.4.1117-1118.2000","article-title":"Antiretroviral-drug concentrations in semen","volume":"44","author":"Gallicano","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.116.073957_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2125.1993.tb04208.x","article-title":"Pharmacokinetics of zidovudine after the initial single dose and during chronic-dose therapy in HIV-infected patients","volume":"36","author":"Gallicano","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1365-2125.2012.04363.x","article-title":"A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4","volume":"74","author":"Gaohua","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib26","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1124\/dmd.110.032649","article-title":"Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data","volume":"38","author":"Gertz","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073957_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2125.1995.tb04455.x","article-title":"Metabolism of theophylline by cDNA-expressed human cytochromes P-450","volume":"39","author":"Ha","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.RES.10.4.598","article-title":"Molecular form of theophylline responsible for positive inotropic activity","volume":"10","author":"Hardman","year":"1962","journal-title":"Circ Res"},{"key":"10.1124\/dmd.116.073957_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.116.073957_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2165\/00003088-198814030-00004","article-title":"The significance of plasma protein binding on the fetal\/maternal distribution of drugs at steady-state","volume":"14","author":"Hill","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.116.073957_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2125.1992.tb04024.x","article-title":"Extrahepatic metabolism of zidovudine","volume":"33","author":"Howe","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/js9803205","article-title":"MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening","volume":"88","author":"Irvine","year":"1999","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.116.073957_bib33","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/clpt.1983.107","article-title":"Placental transfer and maternal midazolam kinetics","volume":"33","author":"Kanto","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.116.073957_bib34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/dmd.112.050161","article-title":"A physiologically based pharmacokinetic model to predict disposition of CYP2D6 and CYP1A2 metabolized drugs in pregnant women","volume":"41","author":"Ke","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073957_bib35","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1038\/psp.2012.2","article-title":"A PBPK model to predict disposition of CYP3A-metabolized drugs in pregnant women: verification and discerning the site of CYP3A induction","volume":"1","author":"Ke","year":"2012","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib36","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bcp.12207","article-title":"Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19","volume":"77","author":"Ke","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/dmd.108.023853","article-title":"Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes","volume":"37","author":"Kilford","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073957_bib38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1248\/bpb.27.753","article-title":"Conditionally immortalized syncytiotrophoblast cell lines as new tools for study of the blood-placenta barrier","volume":"27","author":"Kitano","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.116.073957_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/clpt.1987.49","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of 3\u2032-azido-3\u2032-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases","volume":"41","author":"Klecker","year":"1987","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.116.073957_bib40","doi-asserted-by":"crossref","unstructured":"Knights KM, Spencer SM, Fallon JK, Chau N, Smith PC, and Miners JO (2016) Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance. Br J Clin Pharmacol. 81:1153-1164.","DOI":"10.1111\/bcp.12889"},{"key":"10.1124\/dmd.116.073957_bib41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/dmd.104.003301","article-title":"Possible involvement of organic anion transporter 2 on the interaction of theophylline with erythromycin in the human liver","volume":"33","author":"Kobayashi","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073957_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/infdis\/161.2.203","article-title":"Transfer of zidovudine (AZT) by human placenta","volume":"161","author":"Liebes","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1124\/dmd.116.073957_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/15287394.2012.722523","article-title":"Development of PBPK models for PFOA and PFOS for human pregnancy and lactation life stages","volume":"76","author":"Loccisano","year":"2013","journal-title":"J Toxicol Environ Health A"},{"key":"10.1124\/dmd.116.073957_bib44","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1124\/jpet.102.039255","article-title":"Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs","volume":"303","author":"Mahar Doan","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.073957_bib45","series-title":"Drug Transporters","first-page":"341","article-title":"Drug transport in the placenta","author":"Mao","year":"2014"},{"key":"10.1124\/dmd.116.073957_bib46","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/jps.20149","article-title":"Usefulness of a novel Caco-2 cell perfusion system. I. In vitro prediction of the absorption potential of passively diffused compounds","volume":"93","author":"Masungi","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.116.073957_bib47","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1208\/ps040104","article-title":"Protein binding predictions in infants","volume":"4","author":"McNamara","year":"2002","journal-title":"AAPS PharmSci"},{"key":"10.1124\/dmd.116.073957_bib48","doi-asserted-by":"crossref","unstructured":"Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernandez-Diaz S; National Birth Defects Prevention Study (2011) Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol 205:51.e1-8.","DOI":"10.1016\/j.ajog.2011.02.029"},{"key":"10.1124\/dmd.116.073957_bib49","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0002-9378(11)90791-1","article-title":"The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082)","volume":"168","author":"O\u2019Sullivan","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/dmd.116.073957_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/dmd.108.023598","article-title":"Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction","volume":"37","author":"Ohno","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073957_bib51","first-page":"101","article-title":"Theophylline transfer across human placental cotyledon during in vitro dual perfusion","volume":"23","author":"Omarini","year":"1992","journal-title":"J Med"},{"key":"10.1124\/dmd.116.073957_bib52","unstructured":"Polin RA, Fox WW, Abman SH (2004) Fetal and Neonatal Physiology, W.B. Saunders, Philadelphia."},{"key":"10.1124\/dmd.116.073957_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/00016348409155499","article-title":"Maternal-fetal transfer of aminophylline","volume":"63","author":"Ron","year":"1984","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1124\/dmd.116.073957_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000441-199001000-00005","article-title":"Azidothymidine (zidovudine) transport by the human placenta","volume":"299","author":"Schenker","year":"1990","journal-title":"Am J Med Sci"},{"key":"10.1124\/dmd.116.073957_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01059398","article-title":"Pharmacokinetic parameter estimates from several least squares procedures: superiority of extended least squares","volume":"13","author":"Sheiner","year":"1985","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.116.073957_bib56","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bcp.2014.09.025","article-title":"Identification of CYP3A7 for glyburide metabolism in human fetal livers","volume":"92","author":"Shuster","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib57","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/clpt.1992.79","article-title":"Clinical pharmacokinetics of 3\u2032-azido-3\u2032-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3\u2032-amino-3\u2032-deoxythymidine","volume":"51","author":"Stagg","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.116.073957_bib58","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/jpet.300.3.918","article-title":"Human organic anion transporters and human organic cation transporters mediate renal antiviral transport","volume":"300","author":"Takeda","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.073957_bib59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cpt.382","article-title":"Pregnancy-related pharmacokinetic changes","volume":"100","author":"Tasnif","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.116.073957_bib60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0928-0987(02)00015-5","article-title":"Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I-IV","volume":"15","author":"Taub","year":"2002","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.116.073957_bib61","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1208\/s12248-010-9176-2","article-title":"Comparison of drug permeabilities and BCS classification: three lipid-component PAMPA system method versus Caco-2 monolayers","volume":"12","author":"Teksin","year":"2010","journal-title":"AAPS J"},{"key":"10.1124\/dmd.116.073957_bib62","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/A:1023433502647","article-title":"Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate","volume":"20","author":"Tolle-Sander","year":"2003","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.116.073957_bib63","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ajog.2004.08.030","article-title":"Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy","volume":"192","author":"Tracy","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/dmd.116.073957_bib64","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9378(99)70175-4","article-title":"In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus","volume":"180","author":"Tuntland","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/dmd.116.073957_bib65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.1994.tb04361.x","article-title":"Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells","volume":"38","author":"Veal","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.116.073957_bib66","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1124\/dmd.30.8.883","article-title":"Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7","volume":"30","author":"Williams","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073957_bib67","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.116.073957_bib68","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1023\/A:1011930411574","article-title":"Correlating partitioning and caco-2 cell permeability of structurally diverse small molecular weight compounds","volume":"15","author":"Yazdanian","year":"1998","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.116.073957_bib69","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/toxsci\/kfr141","article-title":"Physiologically based pharmacokinetic modeling of fetal and neonatal manganese exposure in humans: describing manganese homeostasis during development","volume":"122","author":"Yoon","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.116.073957_bib70","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/mol.107.043851","article-title":"Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course","volume":"74","author":"Zhang","year":"2008","journal-title":"Mol Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.116.073957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:21:36Z","timestamp":1739902896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624053303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0090955624053303"],"URL":"https:\/\/doi.org\/10.1124\/dmd.116.073957","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the Model for Passive Placental Permeability Drugs","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.116.073957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}